dc.creatorPetta, CA
dc.creatorOsis, MJD
dc.creatorde Padua, KS
dc.creatorBahamondes, L
dc.creatorMakuch, MY
dc.date2010
dc.dateJAN
dc.date2014-11-14T19:29:06Z
dc.date2015-11-26T17:16:38Z
dc.date2014-11-14T19:29:06Z
dc.date2015-11-26T17:16:38Z
dc.date.accessioned2018-03-29T00:04:48Z
dc.date.available2018-03-29T00:04:48Z
dc.identifierInternational Journal Of Gynecology & Obstetrics. Elsevier Ireland Ltd, v. 108, n. 1, n. 40, n. 43, 2010.
dc.identifier0020-7292
dc.identifierWOS:000273911000011
dc.identifier10.1016/j.ijgo.2009.07.041
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/80981
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/80981
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/80981
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1282331
dc.descriptionObjective: To describe the perspectives and attitudes of Brazilian women toward premenstrual syndrome (PMS). Methods: An exploratory study was conducted in 6 major cities: 1 in each geographic region of Brazil and I in the Federal District Participants were women aged 18-40 years who consulted at public healthcare services or who were members of staff/faculty at university. Results: Of 1053 women, 96.1% had heard of PMS; 65.4% considered that all or almost all women experienced the condition; 87.5% stated that symptoms occurred prior to menstruation; and 60.3% thought that they had PMS at the time of the interview. The emotional and physical symptoms most frequently mentioned were nervousness/anxiety (76.4%); mood swings/crying (55.7%); pain, swelling, and tenderness of the breasts (37.3%); and cramps (45.4%). Conclusion: Premenstrual syndrome was reported by a large number of Brazilian women: actions need to be taken to provide more effectively the specific information required by both lay people and healthcare professionals. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
dc.description108
dc.description1
dc.description40
dc.description43
dc.descriptionBayer Schering Pharma, Brazil
dc.languageen
dc.publisherElsevier Ireland Ltd
dc.publisherClare
dc.publisherIrlanda
dc.relationInternational Journal Of Gynecology & Obstetrics
dc.relationInt. J. Gynecol. Obstet.
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjectPerspective
dc.subjectPremenstrual syndrome
dc.subjectStrategies
dc.subjectDysphoric Disorder
dc.subjectEpidemiology
dc.subjectCommunity
dc.subjectSymptoms
dc.subjectImpact
dc.subjectSample
dc.titlePremenstrual syndrome as reported by Brazilian women
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución